636 related articles for article (PubMed ID: 22519663)
1. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method.
Kushida I; Gotoda M
Drug Dev Ind Pharm; 2013 Oct; 39(10):1582-8. PubMed ID: 22519663
[TBL] [Abstract][Full Text] [Related]
2. Improvement of dissolution and oral absorption of ER-34122, a poorly water-soluble dual 5-lipoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion.
Kushida I; Ichikawa M; Asakawa N
J Pharm Sci; 2002 Jan; 91(1):258-66. PubMed ID: 11782915
[TBL] [Abstract][Full Text] [Related]
3. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
[TBL] [Abstract][Full Text] [Related]
4. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of emulsified solid dispersions containing docetaxel.
Chen Y; Shi Q; Chen Z; Zheng J; Xu H; Li J; Liu H
Arch Pharm Res; 2011 Nov; 34(11):1909-17. PubMed ID: 22139690
[TBL] [Abstract][Full Text] [Related]
6. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion.
Albers J; Alles R; Matthée K; Knop K; Nahrup JS; Kleinebudde P
Eur J Pharm Biopharm; 2009 Feb; 71(2):387-94. PubMed ID: 18951978
[TBL] [Abstract][Full Text] [Related]
8. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
9. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method.
Douroumis D; Bouropoulos N; Fahr A
J Pharm Pharmacol; 2007 May; 59(5):645-53. PubMed ID: 17524229
[TBL] [Abstract][Full Text] [Related]
11. Investigation of atypical dissolution behavior of an encapsulated amorphous solid dispersion.
Puri V; Dantuluri AK; Bansal AK
J Pharm Sci; 2011 Jun; 100(6):2460-8. PubMed ID: 21246560
[TBL] [Abstract][Full Text] [Related]
12. Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat.
Kini A; Patel SB
Pharm Dev Technol; 2017 Feb; 22(1):45-57. PubMed ID: 26853838
[TBL] [Abstract][Full Text] [Related]
13. Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
Ambrogi V; Perioli L; Marmottini F; Rossi C
Eur J Pharm Biopharm; 2007 May; 66(2):253-9. PubMed ID: 17123798
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
15. Formulation optimization of solid dispersion of mosapride hydrochloride.
Kim HJ; Lee SH; Lim EA; Kim JS
Arch Pharm Res; 2011 Sep; 34(9):1467-75. PubMed ID: 21975808
[TBL] [Abstract][Full Text] [Related]
16. Cryomilling-induced solid dispersion of poor glass forming/poorly water-soluble mefenamic acid with polyvinylpyrrolidone K12.
Kang N; Lee J; Choi JN; Mao C; Lee EH
Drug Dev Ind Pharm; 2015 Jun; 41(6):978-88. PubMed ID: 24849785
[TBL] [Abstract][Full Text] [Related]
17. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
18. The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.
Milne M; Liebenberg W; Aucamp M
AAPS PharmSciTech; 2015 Oct; 16(5):1190-202. PubMed ID: 25732372
[TBL] [Abstract][Full Text] [Related]
19. Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability.
Wegiel LA; Zhao Y; Mauer LJ; Edgar KJ; Taylor LS
Pharm Dev Technol; 2014 Dec; 19(8):976-86. PubMed ID: 24192454
[TBL] [Abstract][Full Text] [Related]
20. Amorphous drug-PVP dispersions: application of theoretical, thermal and spectroscopic analytical techniques to the study of a molecule with intermolecular bonds in both the crystalline and pure amorphous state.
Tobyn M; Brown J; Dennis AB; Fakes M; Gao Q; Gamble J; Khimyak YZ; McGeorge G; Patel C; Sinclair W; Timmins P; Yin S
J Pharm Sci; 2009 Sep; 98(9):3456-68. PubMed ID: 19603506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
